Curcumin ameliorates macrophage infiltration by inhibiting NF-B activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy

Nutrition and Metabolism

Volumn 8, Issue , 2011, Pages

  Soetikno, Vivian ^a,b   Sari, Flori R ^a   Veeraveedu, Punniyakoti T ^a   Thandavarayan, Rajarajan A ^a   Harima, Meilei ^a   Sukumaran, Vijayakumar ^a   Lakshmanan, Arun Prasath ^a   Suzuki, Kenji ^c   Kawachi, Hiroshi ^c   Watanabe, Kenichi ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b UNIVERSITY OF INDONESIA   (Indonesia)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; DIABETIC NEPHROPATHY; DRUG EFFECT; MACROPHAGE; MALE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

RATTUS;

EID: 79958151875     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-8-35     Document Type: Article

References (58)

1. Diabetes Incidence Study in Sweden (DISS). Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). M Svensson G Sundkvist HJ Arnqvist E Björk G Blohmé J Bolinder M Henricsson L Nyström O Torffvit I Waernbaum J Ostman JW Eriksson, Diabetes Care 2003 26 2903 2909 10.2337/diacare.26.10.2903 14514599 (Pubitemid 37205566)
2. Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease. KR Tuttle, J Am Soc Nephrol 2005 16 1537 1538 10.1681/ASN.2005040393 15872083 (Pubitemid 41716459)
3. The role of macrophages in diabetic glomerulosclerosis. T Furuta T Saito T Ootaka J Soma K Obara K Abe K Yoshinaga, Am J Kidney Dis 1993 21 480 485 8488815 (Pubitemid 23160508)
4. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. F Chow E Ozols DJ Nikolic-Paterson RC Atkins GH Tesch, Kidney Int 2004 65 116 128 10.1111/j.1523-1755.2004.00367.x 14675042 (Pubitemid 38037496)
5. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. C Sassy-Prigent D Heudes C Mandet MF Bélair O Michel B Perdereau J Bariéty P Bruneval, Diabetes 2000 49 466 475 10.2337/diabetes.49.3.466 10868970 (Pubitemid 30131794)
6. ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. B Amann R Tinzmann B Angelkort, Diabetes Care 2003 26 2421 2425 10.2337/diacare.26.8.2421 12882873 (Pubitemid 36993337)
7. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. T Wada K Furuichi N Sakai Y Iwata K Yoshimoto M Shimizu SI Takeda K Takasawa M Yoshimura H Kida KI Kobayashi N Mukaida T Naito K Matsushima H Yokoyama, Kidney Int 2000 58 1492 1499 10.1046/j.1523-1755.2000.00311.x 11012884
8. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. N Banba T Nakamura M Matsumura H Kuroda Y Hattori K Kasai, Kidney Int 2000 58 684 690 10.1046/j.1523-1755.2000.00214.x 10916091 (Pubitemid 30620017)
9. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. FY Chow DJ Nikolic-Paterson E Ozols RC Atkins BJ Rollin GH Tesch, Kidney Int 2006 69 73 80 10.1038/sj.ki.5000014 16374426 (Pubitemid 43117741)
10. Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. FY Chow DJ Nikolic-Paterson RC Atkins GH Tesch, Nephrol Dial Transplant 2004 19 2987 2996 10.1093/ndt/gfh441 15574996 (Pubitemid 40057619)
11. Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. H Sugimoto K Shikata K Hirata K Akiyama M Matsuda M Kushiro Y Shikata N Miyatake M Miyasaka H Makino, Diabetes 1997 46 2075 2081 10.2337/diabetes.46.12.2075 9392499 (Pubitemid 27512099)
12. Transcription factor-kappa B (NF-kappa B) and renal disease. C Guijarro J Egido, Kidney Int 2001 59 415 424 10.1046/j.1523-1755.2001.059002415.x 11168923 (Pubitemid 32157906)
13. High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappaB-dependent. CW Park JH Kim JH Lee YS Kim HJ Ahn YS Shin SY Kim EJ Choi YS Chang BK Bang, Diabetologia 2000 43 1544 1553 10.1007/s001250051567 11151765 (Pubitemid 32734862)
14. Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-B signaling pathway. Q Jiang P Liu X Wu W Liu X Shen T Lan S Xu J Peng X Xie H Huang, Mol Cell Endocrinol 2011 331 34 40 10.1016/j.mce.2010.07.023 20674665
15. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. S Mezzano C Aros A Droguett ME Burgos L Ardiles C Flores H Schneider M Ruiz-Ortega J Egido, Nephrol Dial Transplant 2004 19 2505 2512 10.1093/ndt/gfh207 15280531 (Pubitemid 39360096)
16. Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus. A Riad J Du S Stiehl D Westermann Z Mohr M Sobirey W Doehner V Adams M Pauschinger HP Schultheiss C Tschöpe, Eur J Pharmacol 2007 569 204 211 10.1016/j.ejphar.2007.04.065 17669395 (Pubitemid 47202015)
17. Curcumin: from ancient medicine to current clinical trials. H Hatcher R Planalp J Cho FM Torti SV Torti, Cell Mol Life Sci 2008 65 1631 1652 10.1007/s00018-008-7452-4 18324353
18. Curcumin: getting back to the roots. S Shishodia G Sethi BB Aggarwal, Ann N Y Acad Sci 2005 1056 206 217 10.1196/annals.1352.010 16387689 (Pubitemid 43030979)
19. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. S Aggarwal H Ichikawa Y Takada SK Sandur S Shishodia BB Aggarwal, Mol Pharmacol 2006 69 195 206 16219905 (Pubitemid 43048906)
20. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. J Chiu ZA Khan H Farhangkhoee S Chakrabarti, Nutrition 2009 25 964 972 10.1016/j.nut.2008.12.007 19268536
21. Attenuation of renal fibrosis by curcumin in rat obstructive nephropathy. N Kuwabara S Tamada T Iwai K Teramoto N Kaneda T Yukimura T Nakatani K Miura, Urology 2006 67 440 446 10.1016/j.urology.2005.09.028 16461119 (Pubitemid 43189889)
22. Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy. K Watanabe Y Ohta M Nakazawa H Higuchi G Hasegawa M Naito K Fuse M Ito S Hirono N Tanabe H Hanawa K Kato M Kodama Y Aizawa, Br J Pharmacol 2000 130 1489 1495 10.1038/sj.bjp.0703450 10928949 (Pubitemid 30611923)
23. Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. SK Jain J Rains J Croad B Larson K Jones, Antioxid Redox Signal 2009 11 241 249 10.1089/ars.2008.2140 18976114
24. Preventive effect of garlic juice on renal reperfusion injury. F Bagheri A Gol S Dabiri A Javadi, Iran J Kidney Dis 2011 5 194 200 21525580
25. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. V Thallas-Bonke SR Thorpe MT Coughlan K Fukami FY Yap KC Sourris SA Penfold LA Bach ME Cooper JM Forbes, Diabetes 2008 57 460 469 17959934
26. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation. S Ohga K Shikata K Yozai S Okada D Ogawa H Usui J Wada Y Shikata H Makino, Am J Physiol Renal Physiol 2007 292 1141 F1150 17190910
27. 14-3-3 protein regulates Ask1 signaling and protects against diabetic cardiomyopathy. RA Thandavarayan K Watanabe M Ma PT Veeraveedu N Gurusamy SS Palaniyandi S Zhang AJ Muslin M Kodama Y Aizawa, Biochem Pharmacol 2008 75 1797 1806 10.1016/j.bcp.2008.02.003 18342293
28. Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation. SS Ghosh HD Massey R Krieg ZA Fazelbhoy S Ghosh DA Sica I Fakhry TW Gehr, Am J Physiol Renal Physiol 2009 296 1146 F1157 10.1152/ajprenal.90732. 2008 19225048
29. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Y Abe S Hashimoto T Horie, Pharmacol Res 1999 39 41 47 10.1006/phrs.1998.0404 10051376
30. Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity. A Kuhad S Pilkhwal S Sharma N Tirkey K Chopra, J Agric Food Chem 2007 55 10150 10155 10.1021/jf0723965 18001039
31. Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats. SS Ghosh FN Salloum A Abbate R Krieg DA Sica TW Gehr RC Kukreja, Am J Physiol Heart Circ Physiol 2010 299 975 H984 10.1152/ajpheart.00154.2010 20601462
32. Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys. N Tirkey G Kaur G Vij K Chopra, BMC Pharmacol 2005 5 15 10.1186/1471-2210-5-15 16225695
33. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. SP Weisberg R Leibel DV Tortoriello, Endocrinology 2008 149 3549 3558 10.1210/en.2008-0262 18403477 (Pubitemid 351919581)
34. Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes. HM Woo JH Kang T Kawada H Yoo MK Sung R Yu, Life Sci 2007 13 926 931 (Pubitemid 46186427)
35. Activation of NFkappaB and Ub-proteasome pathway during apoptosis induced by a serum factor is mediated through the upregulation of the 26S proteasome subunits. S Singh A Khar, Apoptosis 2006 11 845 859 10.1007/s10495-006-5878-4 16532374 (Pubitemid 43876852)
36. Role of inflammation in diabetic complications. JF Navarro C Mora, Nephrol Dial Transplant 2005 20 2601 2604 10.1093/ndt/gfi155 16188894 (Pubitemid 41672253)
37. Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. PP Wolkow MA Niewczas B Perkins LH Ficociello B Lipinski JH Warram AS Krolewski, J Am Soc Nephrol 2008 19 789 797 10.1681/ASN.2007050556 18256362
38. Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. H Schmid A Boucherot Y Yasuda A Henger B Brunner F Eichinger A Nitsche E Kiss M Bleich HJ Gröne PJ Nelson D Schlöndorff CD Cohen M Kretzler, Diabetes 2006 55 2993 3003 10.2337/db06-0477 17065335 (Pubitemid 44923635)
39. Phosphorylation of serine 276 is essential for p65 NF-kappaB subunit-dependent cellular responses. T Okazaki S Sakon T Sasazuki H Sakurai T Doi H Yagita K Okumura H Nakano, Biochem Biophys Res Commun 2003 300 807 812 10.1016/S0006-291X(02)02932-7 12559944 (Pubitemid 36259833)
40. L-cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, and oxidative stress and inhibits NF-kappaB activation in the livers of Zucker diabetic rats. SK Jain T Velusamy JL Croad JL Rains R Bull, Free Radic Biol Med 2009 46 1633 1638 10.1016/j.freeradbiomed.2009.03.014 19328229
41. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). S Singh BB Aggarwal, J Biol Chem 1995 270 24995 5000 10.1074/jbc.270.42.24995 7559628
42. Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation. Y Ikezumi LA Hurst T Masaki RC Atkins DJ Nikolic-Paterson, Kidney Int 2003 63 83 95 12472771 (Pubitemid 35463909)
43. The role of macrophages in glomerulonephritis. DJ Nikolic-Paterson RC Atkins, Nephrol Dial Transplant 2001 16 3 7 11509677 (Pubitemid 32750422)
44. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. FY Chow DJ Nikolic-Paterson E Ozols RC Atkins GH Tesch, J Am Soc Nephrol 2005 16 1711 1722 10.1681/ASN.2004070612 15857924 (Pubitemid 41716477)
45. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. S Okada K Shikata M Matsuda D Ogawa H Usui Y Kido R Nagase J Wada Y Shikata H Makino, Diabetes 2003 52 2586 2593 10.2337/diabetes.52.10.2586 14514644 (Pubitemid 37210549)
46. Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. FY Chow DJ Nikolic-Paterson FY Ma E Ozols BJ Rollins GH Tesch, Diabetologia 2007 50 471 480 10.1007/s00125-006-0497-8 17160673
47. Intercellular adhesion molecule-1 gene expression in human endothelial cells. Differential regulation by tumor necrosis factor-alpha and phorbol myristate acetate. SJ Wertheimer CL Myers RW Wallace TP Parks, J Biol Chem 1992 267 12030 12035 1351055
48. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. T Marumo VB Schini-Kerth R Busse, Diabetes 1999 48 1131 1137 10.2337/diabetes.48.5.1131 10331420 (Pubitemid 29226362)
49. Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. H Ha MR Yu YJ Choi M Kitamura HB Lee, J Am Soc Nephrol 2002 13 894 902 11912248 (Pubitemid 34274085)
50. Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. S Chen B Jim FN Ziyadeh, Semin Nephrol 2003 23 532 543 10.1053/S0270-9295(03)00132-3 14631561 (Pubitemid 38030087)
51. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. FN Ziyadeh BB Hoffman DC Han MC Iglesias-De La Cruz SW Hong M Isono S Chen TA McGowan K Sharma, Proc Natl Acad Sci USA 2000 97 8015 8020 10.1073/pnas. 120055097 10859350 (Pubitemid 30460765)
52. Glycated albumin increases oxidative stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells. MP Cohen E Shea S Chen CW Shearman, J Lab Clin Med 2003 141 242 249 10.1067/mlc.2003.27 12677169 (Pubitemid 36432924)
53. Regulation and consequences of differential gene expression in diabetic kidney disease. M Murphy J Crean DP Brazil D Sadlier F Martin C Godson, Biochem Soc Trans 2008 36 941 945 10.1042/BST0360941 18793165
54. Macrophages promote prosclerotic responses in cultured rat mesangial cells: a mechanism for the initiation of glomerulosclerosis. IZ Pawluczyk KP Harris, J Am Soc Nephrol 1997 8 1525 1536 9335380 (Pubitemid 27496470)
55. The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. G Leonarduzzi A Scavazza F Biasi E Chiarpotto S Camandola S Vogel R Dargel G Poli, FASEB J 1997 11 851 857 9285483 (Pubitemid 27371894)
56. Cellular events in the evolution of experimental diabetic nephropathy. BA Young RJ Johnson CE Alpers E Eng K Gordon J Floege WG Couser K Seidel, Kidney Int 1995 47 935 944 10.1038/ki.1995.139 7752595
57. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. C Sassy-Prigent D Heudes C Mandet MF Bélair O Michel B Perdereau J Bariéty P Bruneval, Diabetes 2000 49 466 475 10.2337/diabetes.49.3.466 10868970 (Pubitemid 30131794)
58. NF-kappa B involved in transcription enhancement of TGF-beta 1 induced by Ox-LDL in rat mesangial cells. Y Lan Q Zhou ZL Wu, Chin Med J (Engl) 2004 117 225 230 (Pubitemid 38351448)